The study highlights differences between patients with systemic lupus erythematosus (SLE) and healthy controls, potentially shedding light on the disease’s underlying mechanisms. A new “multi-omics” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback